MRMD Stock Overview
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally.
MariMed Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$0.44|
|52 Week High||US$0.99|
|52 Week Low||US$0.40|
|1 Month Change||-28.92%|
|3 Month Change||-2.22%|
|1 Year Change||-52.69%|
|3 Year Change||-51.92%|
|5 Year Change||-8.33%|
|Change since IPO||10.00%|
Recent News & Updates
|MRMD||US Pharmaceuticals||US Market|
Return vs Industry: MRMD underperformed the US Pharmaceuticals industry which returned 3% over the past year.
Return vs Market: MRMD underperformed the US Market which returned -23.7% over the past year.
|MRMD Average Weekly Movement||8.4%|
|Pharmaceuticals Industry Average Movement||11.5%|
|Market Average Movement||6.9%|
|10% most volatile stocks in US Market||15.7%|
|10% least volatile stocks in US Market||2.8%|
Stable Share Price: MRMD is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: MRMD's weekly volatility (8%) has been stable over the past year.
About the Company
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company offers cannabis genetics produce flowers and concentrates under the Nature’s Heritage brand; cannabis-infused products in the form of chewable tablets and powder drink mixes under the brand Kalm Fusion; natural fruit chews under the Betty’s Eddies brand; brownies, cookies, and other social sweets under the Bubby’s Baked brand; and cannabidiol formulations under the Florance brand. It also licenses its brands and product formulations, as well as leases cannabis facilities.
MariMed Inc. Fundamentals Summary
|MRMD fundamental statistics|
Is MRMD overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|MRMD income statement (TTM)|
|Cost of Revenue||US$62.87m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||0.0045|
|Net Profit Margin||1.18%|
How did MRMD perform over the long term?See historical performance and comparison